Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the rat
- PMID: 2569216
- DOI: 10.1007/BF00444690
Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the rat
Abstract
The effect of chronic D-1 and/or D-2 dopamine receptor blockade on apomorphine-induced behaviors was studied in rats treated for 21 days with the selective D-1 antagonist SCH23390, the predominantly D-2 antagonist haloperidol, and the combination of the two drugs at the same daily doses (0.1 and 1 mg/kg respectively). Apomorphine (0.3 mg/kg) 4 days following the last injection of the drugs increased (49-70%) stereotypic behavior in all animals as compared to saline-treated controls. Although the SCH23390-induced increase was lower than haloperidol-induced supersensitivity, stereotypies after combined administration of both drugs did not differ significantly from either, suggesting that the effects of the two drugs are not additive. Underlying receptor changes and modified D-1/D-2 receptor interactions may account for the participation of both receptor subtypes to the development of neuroleptic-induced dopaminergic supersensitivity.
Similar articles
-
Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.Eur J Pharmacol. 1988 Mar 29;148(2):269-72. doi: 10.1016/0014-2999(88)90573-0. Eur J Pharmacol. 1988. PMID: 2897925
-
Enhanced stereotyped response to apomorphine after chronic D-1 blockade with SCH 23390.Psychopharmacology (Berl). 1987;91(3):394-6. doi: 10.1007/BF00518199. Psychopharmacology (Berl). 1987. PMID: 2882541
-
D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity.Pharmacol Biochem Behav. 1993 May;45(1):195-200. doi: 10.1016/0091-3057(93)90104-2. Pharmacol Biochem Behav. 1993. PMID: 8516358
-
Repeated treatment with (-)-sulpiride plus a low dose of SCH 23390 displays wider neuroleptic activity without inducing dopaminergic supersensitivity.Psychopharmacology (Berl). 1990;100(4):560-2. doi: 10.1007/BF02244013. Psychopharmacology (Berl). 1990. PMID: 1969667
-
Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.Psychopharmacology (Berl). 1993;113(2):157-66. doi: 10.1007/BF02245692. Psychopharmacology (Berl). 1993. PMID: 7855176
Cited by
-
Effects of kappa receptor agonists on D1 and D2 dopamine agonist and antagonist-induced behaviors.Psychopharmacology (Berl). 1996 Jan;123(2):215-21. doi: 10.1007/BF02246181. Psychopharmacology (Berl). 1996. PMID: 8741947
-
Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.J Neural Transm (Vienna). 1997;104(4-5):341-62. doi: 10.1007/BF01277656. J Neural Transm (Vienna). 1997. PMID: 9295170 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources